Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: are concentrations required clinically achievable?

J Intern Med. 2021 Jun;289(6):926-927. doi: 10.1111/joim.13264. Epub 2021 Feb 25.

X Solanich¹, N Padullés², J Niubó³, S Videla⁴, A Antolí¹, G Rocamora-Blanch¹, X Corbella^{1

5}

¹ From the, Department of Internal Medicine, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
² Department of Pharmacy, Bellvitge University Hospital, Bellvit, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
³ Department of Microbiology, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
⁴ Department of Clinical Pharmacology, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
⁵ School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain.

No abstract available

Publication types